Pancreatic Neuroendocrine Tumors
636 articles
Learn More About Qualifying for Clinical Trials
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
Genetic Testing Can Help Those You Love
Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites
Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
Can AI Help Detect Pancreatic Cancer Early?
Dr. Mimi Canto is leading a cross-disciplinary group of researchers who are working to use AI for early detection of pancreatic cancer.
What Drives Pancreatic Cancer Spread?
Dr. Gina Razidlo and her team focus on how stop metastasis–pancreatic cancer spreading–to aid in drug development.
Eating Right Can Help Your Pancreatic Cancer Fight
Pancreatic cancer patients can potentially combat side effects of treatment through a proper diet, according to advice from oncology dietitian Maria Petzel.
Exploring Alternatives to Creon for Pancreatic Enzyme Replacement Therapy
Oncology dietitian Meghan Laszlo explains how pancreatic enzyme replacement drug Creon works and available alternatives.
Pancreatic Cancer Pathology: How Doctors Get to a Diagnosis
Dr. Jingxin Qiu explains the role of pathology in grading a tumor and staging cancer, to help patients understand the pancreatic cancer diagnosis.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
Pancreatic Cancer Patients Have a Role in Treatment Choices
Pancreatic Cancer UK’s Peter De Rosa explains how patient-reported outcome measures can help direct treatment choices and supportive care.